Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Analysis of Oncogenic Cooperation during Leukemia Progression by Single Cell RNA-seq

ABSTRACT: Analysis of Oncogenic Cooperation during Leukemia Progression by Single Cell RNA-seq

PROVIDER: PRJNA742078 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR12396124_1.fastq.gz	Fastqsanger.gz
	SRR12396124_2.fastq.gz	Fastqsanger.gz
	SRR12396125_1.fastq.gz	Fastqsanger.gz
	SRR12396125_2.fastq.gz	Fastqsanger.gz
	SRR12396126_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 32

Similar Datasets

Oncogene cooperation in human leukemia

Project description:Oncogene cooperation in human leukemia

| PRJNA940078 | ENA

Analysis of Oncogenic Cooperation during Leukemia Progression by Single Cell RNA-seq

Project description:This SuperSeries is composed of the SubSeries listed below.

2021-09-28 | GSE179084 | GEO

Oncogene cooperation in human leukemia

Project description:Validation of previously defined oncogene cooperativity signature across various human leukemia types. Additionaly, to characterize functional impact of these genes and defined network interactions that drive leukemia progression and survival.

2025-04-04 | GSE226372 | GEO

Enhancer engagement sustains oncogenic transformation and progression of B-cell precursor acute lymphoblastic leukemia

Project description:Enhancer engagement sustains oncogenic transformation and progression of B-cell precursor acute lymphoblastic leukemia

| PRJNA887733 | ENA

A systems biology approach in understanding oncogenic cooperation between TAL1 expression and PTEN deletion in T-cell acute lymphoblastic leukaemia

Project description:T-cell acute lymphoblastic leukemia (T-ALL) is caused by the accumulation of multiple mutations combined with the ectopic expression of transcription factors. However, how these transcription factors cooperate with oncogenic mutations has been difficult to assess due to a lack of robust T cell model systems. Here we utilize a new ex vivo pro-T cell model to study oncogenic cooperation. Using a systems biological approach we dissect the pro-T cell signaling network driven by interleukin-7, stem cell factor (Scf) and Notch1 and identify downstream Akt, Stat, E2f and Myc genetic signaling networks. Furthermore, we demonstrate that ectopic expression of the TAL1 transcription factor and PTEN deletion are bona-fide cooperating events leading to Scf addiction and metabolic reprogramming, partially through upregulation of the lactate transporter Mct4. This ex vivo pro-T cell system is a powerful new model system to understand transforming events and the identification of new therapeutic targets in T-cell malignancies.

2018-05-15 | GSE98899 | GEO

PRMT5 Promotes Progression of Chronic Lymphocytic Leukemia [ATAC-Seq]

Project description:Purpose: Richter’s Transformation (RT) is a poorly understood and often fatal progression of chronic lymphocytic leukemia (CLL) manifesting histologically as diffuse large B-cell lymphoma. PRMT5 is implicated in lymphomagenesis, but its role in CLL or RT progression is unknown. We demonstrate herein that tumors uniformly overexpress PRMT5 in patients with progression to RT. Furthermore, mice with B-specific overexpression of hPRMT5 developed a B-lymphoid expansion with increased risk of death, and Eµ-PRMT5/TCL1 double transgenic mice uniformly developed a highly aggressive disease that histologically resembles RT; where large-scale transcriptional profiling identified unique oncogenic pathways that mediate PRMT5-driven disease progression. Taken together, the discovery that PRMT5 drives oncogenic pathways promoting RT provides a compelling rationale for clinical investigation of PRMT5 inhibitors such as PRT382 in aggressive CLL/RT cases

2022-12-07 | GSE183429 | GEO

PRMT5 Promotes Progression of Chronic Lymphocytic Leukemia [3_vs_6_mo_RNA-Seq]

2022-12-07 | GSE183427 | GEO

PRMT5 Promotes Progression of Chronic Lymphocytic Leukemia [scRNA-Seq]

2022-12-07 | GSE183426 | GEO

Single cell RNA-seq analysis of transcriptomics in WT and E2-KO, G12D and G12D/E2-KO HSPCs from mouse bone marrow

Project description:Cancers develop from the accumulation of somatic mutations, yet it remains unclear how oncogenic lesions cooperate to drive cancer progression. Using a mouse model harboring NRasG12D and EZH2 mutations that recapitulates leukemic progression, we employ single-cell RNA sequencing to map cellular composition and gene expression alterations in healthy or diseased bone marrows underlying leukemia progression. At cellular levels, while NRasG12D induces myeloid-biased differentiation and EZH2-deficiency impairs myeloid maturation, they cooperate to promote myeloid expansion with dysregulated transcriptional programs. At gene levels, NRasG12D and EZH2-deficiency independently or synergistically control gene expression in single cells. We integrate results from histopathology, flow cytometry, leukemia repopulation, and leukemia-initiating cell assays to validate transcriptome-based cellular profiles. We use this resource to relate developmental hierarchies to leukemia phenotypes, evaluate oncogenic cooperation at single-cell levels, and identify new regulators of leukemia-initiating cells. Our studies establish an integrative approach to capture the kinetics of cancer evolution in vivo.

2021-09-28 | GSE155763 | GEO

Loss of CHD1 facilitates oncogenic hijacking of AR during cancer progression

Project description:Loss of CHD1 facilitates oncogenic hijacking of AR during cancer progression

| PRJNA482101 | ENA